• Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis FungoidesRECRUITINGEarly Phase 1NCT05838599
• Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell LymphomaRECRUITINGPhase 2NCT04930653
• Photopheresis in Early-stage Mycosis FungoidesRECRUITINGPhase 2NCT05680558
• Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis FungoidesRECRUITINGPhase 2NCT03398161
• Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell LymphomasRECRUITINGPhase 2NCT05956041
• Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis FungoidesRECRUITINGPhase 2NCT05357794
• A Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesRECRUITINGPhase 1NCT05296304
• Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell LymphomaRECRUITINGPhase 1NCT06508463
• Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell LymphomaRECRUITINGPhase 1/Phase 2NCT03011814
• Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary SyndromeRECRUITINGPhase 2NCT04256018
• Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsRECRUITINGPhase 2NCT03587844
• Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRECRUITINGPhase 2NCT06580002
• A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaRECRUITINGPhase 1NCT07192471
• A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or LymphomaRECRUITINGPhase 1NCT03017820
• Study of ONO-4685 in Patients With Relapsed or Refractory T Cell LymphomaRECRUITINGPhase 1NCT05079282
• Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell LymphomaRECRUITINGPhase 2NCT05996185
• Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's LymphomaRECRUITINGPhase 1NCT05967416
• Auto Stem Cell Transplant for Lymphoma PatientsRECRUITINGPhase 2NCT03125642
• A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care MogamulizumabRECRUITINGNCT07003100
• Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid PapulosisRECRUITINGNCT06207812
• Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis FungoidesRECRUITINGNCT02702310
• ID Of Prognostic Factors In Mycosis Fungoides/Sezary SyndromeRECRUITINGNCT02848274
• A Registry for People With T-cell LymphomaRECRUITINGNCT05978141
• A Study of VG712 in Patients With Mycosis FungoidesNOT_YET_RECRUITINGPhase 2NCT07529405
• Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray SolutionNOT_YET_RECRUITINGEarly Phase 1NCT05728879
• A Study of Topical Duvelisib in Participants With Early-stage Mycosis FungoidesNOT_YET_RECRUITINGPhase 1NCT07714187
• Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic LeukemiaNOT_YET_RECRUITINGPhase 2NCT07682792
• Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body WashENROLLING_BY_INVITATIONNCT06665490
• Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T CellsACTIVE_NOT_RECRUITINGPhase 1NCT03690011

Showing active trials that list “Mycosis Fungoides” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.